Previous 10 | Next 10 |
GAITHERSBURG, Md., July 21, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that Standard & Poor’s (S&P) has indicated that the company will be added to the S&P MidCap 400 ® index, effective prior to the open of trading on Friday, Jul...
NEW YORK , July 20, 2020 /PRNewswire/ -- S&P SmallCap 600 constituent Emergent BioSolutions Inc. (NYSE: EBS) will replace Caesars Entertainment Corp. (NASD: CZR) in the S&P MidCap 400, and First Hawaiian Inc. (NASD:FHB) will replace Emergent BioSolutions in the S&P SmallC...
First Hawaiian (NASDAQ: FHB ) is up 5.3% postmarket after news that it's moving into the S&P SmallCap 600 index . More news on: First Hawaiian, Inc., Emergent BioSolutions Inc., Caesars Entertainment Corporation, Financial stocks news, Stocks on the move, Healthcare stocks news ...
GAITHERSBURG, Md., July 16, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, July 30, 2020 at 5:00 pm (Eastern Time) to discuss the financial results for the second quarter of 2020, recent business developments, revenue guidance for th...
Johnson & Johnson (NYSE: JNJ) has been a leader in the pharmaceutical industry for over 130 years. With a vast product portfolio and a 2.8% dividend yield, the stock remains popular with income investors despite a history of modest year-over-year gains. The company experienced 6.7% sales...
Vaxart (NASDAQ: VXRT) , a biotech company focused on the development of oral vaccines, had an underwhelming performance in the stock market in 2019 with its shares dropping by more than 80%. But largely thanks to the company's efforts to develop a vaccine for COVID-19, the stock has soared by...
Biotech Stocks Are On The Rise Amid News From Novavax When we hear the term coronavirus stocks , it can refer to a broad range of sectors. Depending on the context, it could be the new-economy stocks, spanning from gaming companies and online food delivery to biotech stocks . Like it or not,...
Emergent BioSolutions ( EBS +5.4% ) is partnering with Mount Sinai to test its experimental COVID-19 hyperimmune globulin treatment, COVID-HIG, derived from the blood plasma of recovered Covid-19 patients. More news on: Emergent BioSolutions Inc., Healthcare stocks news, Read ...
Mount Sinai and Emergent to conduct clinical trials to evaluate COVID-HIG for post-exposure prophylaxis of COVID-19 in front-line health care workers and to support a potential Expanded Access Program for military personnel with funding from the U.S. Department of Defense ImmunoTek to ext...
( Pexels ) Of all the investable sectors and industries, one of the top-performing over the past few months is biotechnology. Since its March low (18 th ), the SPDR Biotech ETF ( XBI ) has risen about 75% as investors speculate on virus treatment and vaccine rumors. Understandably, many in...
News, Short Squeeze, Breakout and More Instantly...
Emergent Biosolutions Inc. Company Name:
EBS Stock Symbol:
NYSE Market:
Emergent Biosolutions Inc. Website:
New video and radio segments raise awareness of a potentially life-saving, three-step method that anyone can use to respond in a suspected opioid poisoning GAITHERSBURG, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch of a new opio...
GAITHERSBURG, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 6, 2024, at 5:00 pm eastern time to discuss the financial results for the second quarter 2024, key business updates, revenue guidance for the third quarter of...
The extension to a four-year shelf-life helps improve naloxone access as communities continue to grapple with the growing opioid epidemic; product with the extended shelf life has officially begun shipping WINNIPEG, Manitoba, July 22, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolution...